Imperial College London

Professor Amanda Cross

Faculty of MedicineSchool of Public Health

Professor of Cancer Epidemiology



+44 (0)20 7594 3338amanda.cross




Mr Will Kay +44 (0)20 7594 3350




Room 1089Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus





Professor Cross is a cancer epidemiologist in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group ( the Department of Surgery and Cancer at Imperial.

She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut.  Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.

Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk.



Murphy G, Freedman ND, Abnet CC, et al., 2024, Helicobacter hepaticus and Helicobacter bilis in liver and biliary cancers from ATBC and PLCO, Helicobacter (oxford), Vol:29, ISSN:1083-4389

Meyer A, Dong C, Chan SSM, et al., 2024, Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn's disease and ulcerative colitis, Alimentary Pharmacology & Therapeutics, Vol:59, ISSN:0269-2813, Pages:558-568

Power S, Wooldrage K, Saunders BP, et al., 2024, The impact of endoscopist performance and patient factors on distal adenoma detection and colorectal cancer incidence, Bmc Gastroenterology, Vol:24, ISSN:1471-230X

Pham TT, Nimptsch K, Aleksandrova K, et al., 2024, Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition study, International Journal of Cancer, ISSN:0020-7136

Botteri E, Peveri G, Berstad P, et al., 2024, Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition, European Journal of Epidemiology, ISSN:0393-2990

More Publications